259 related articles for article (PubMed ID: 20425680)
1. [Diabetes, insulin, insulin analogues, and cancer].
Müssig K; Staiger H; Kantartzis K; Fritsche A; Kanz L; Häring HU
Dtsch Med Wochenschr; 2010 May; 135(18):924-9. PubMed ID: 20425680
[TBL] [Abstract][Full Text] [Related]
2. Insulin glargine and receptor-mediated signalling: clinical implications in treating type 2 diabetes.
Le Roith D
Diabetes Metab Res Rev; 2007 Nov; 23(8):593-9. PubMed ID: 17922476
[TBL] [Abstract][Full Text] [Related]
3. [Insulin and cancer: myth or reality?].
Tran C; Gariani K; Philippe J
Rev Med Suisse; 2010 Jun; 6(252):1188-90, 1192. PubMed ID: 20614753
[TBL] [Abstract][Full Text] [Related]
4. Cancer risk in diabetic patients treated with insulin glargine?
Prescrire Int; 2010 Aug; 19(108):162-3. PubMed ID: 20939447
[TBL] [Abstract][Full Text] [Related]
5. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
6. [Safety of insulin analogues: what to evaluate, how to do it, and how to interpret the results].
Hernández Mijares A; Solá Izquierdo E; García Malpartida K; Verge D
Endocrinol Nutr; 2010 Oct; 57(8):376-80. PubMed ID: 20621572
[TBL] [Abstract][Full Text] [Related]
7. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
8. Insulin glargine and cancer risk: an opinion statement of the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy.
Edwards KL; Riche DM; Stroup JS; Goldman-Levine JD; Padiyara RS; Cross LB; Kane MP
Pharmacotherapy; 2010 Sep; 30(9):955-65. PubMed ID: 20795850
[TBL] [Abstract][Full Text] [Related]
9. Diabetes mellitus and increased risk of cancer: focus on metformin and the insulin analogs.
McFarland MS; Cripps R
Pharmacotherapy; 2010 Nov; 30(11):1159-78. PubMed ID: 20973689
[TBL] [Abstract][Full Text] [Related]
10. Insulin glargine (Lantus) and cancer risk.
Med Lett Drugs Ther; 2009 Aug; 51(1319):67-8. PubMed ID: 19696708
[No Abstract] [Full Text] [Related]
11. Type 2 diabetes mellitus and risk of malignancy: is there a strategy to identify a subphenotype of patients with increased susceptibility to endogenous and exogenous hyperinsulinism?
Müssig K; Staiger H; Kantartzis K; Fritsche A; Kanz L; Häring HU
Diabet Med; 2011 Mar; 28(3):276-86. PubMed ID: 21309835
[TBL] [Abstract][Full Text] [Related]
12. Diabetes mellitus type 2 - an independent risk factor for cancer?
Grote VA; Becker S; Kaaks R
Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):4-8. PubMed ID: 20127570
[TBL] [Abstract][Full Text] [Related]
13. New insulins and the risk of cancer.
Danne T; Bolinder J
Int J Clin Pract Suppl; 2010 Feb; (166):26-8. PubMed ID: 20377661
[TBL] [Abstract][Full Text] [Related]
14. Insulin analogues and cancer risk: cause for concern or cause célèbre?
Pollak M; Russell-Jones D
Int J Clin Pract; 2010 Apr; 64(5):628-36. PubMed ID: 20201993
[TBL] [Abstract][Full Text] [Related]
15. Promising new approaches.
Reasner CA
Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
17. Practical approaches to insulin therapy for type 2 diabetes mellitus with premixed insulin analogues.
Rolla AR; Rakel RE
Clin Ther; 2005 Aug; 27(8):1113-25. PubMed ID: 16199240
[TBL] [Abstract][Full Text] [Related]
18. Insulin signal transduction in normal cells and its role in carcinogenesis.
Müssig K; Häring HU
Exp Clin Endocrinol Diabetes; 2010 Jun; 118(6):356-9. PubMed ID: 20140848
[TBL] [Abstract][Full Text] [Related]
19. Energy balance, physical activity, and cancer risk.
Fair AM; Montgomery K
Methods Mol Biol; 2009; 472():57-88. PubMed ID: 19107429
[TBL] [Abstract][Full Text] [Related]
20. Effects of troglitazone on insulin sensitivity.
Henry RR
Diabet Med; 1996 Sep; 13(9 Suppl 6):S148-50. PubMed ID: 8894499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
